Abstract:Cirrhosis is frequently the final stage of disease preceding the development of hepatocellular carcinoma (HCC) and is one of the risk factors for HCC. Preventive surveillance for early HCC in patients with cirrhosis is advantageous for achieving early HCC prevention and diagnosis, thereby enhancing patient prognosis and reducing mortality. However, there is no highly sensitive diagnostic marker for the clinical surveillance of HCC in patients with cirrhosis, which significantly restricts its use in primary care for HCC. To increase the accuracy of illness diagnosis, the study of the effective and sensitive genetic biomarkers involved in HCC incidence is crucial. In this study, a set of 120 significantly differentially expressed genes (DEGs) was identified in the GSE121248 dataset. A protein–protein interaction (PPI) network was constructed among the DEGs, and Cytoscape was used to extract hub genes from the network. In TCGA database, the expression levels, correlation analysis, and predictive performance of hub genes were validated. In total, 15 hub genes showed increased expression, and their positive correlation ranged from 0.80 to 0.90, suggesting they may be involved in the same signaling pathway governing HBV-related HCC. The GSE10143, GSE25097, GSE54236, and GSE17548 datasets were used to investigate the expression pattern of these hub genes in the progression from cirrhosis to HCC. Using Cox regression analysis, a prediction model was then developed. The ROC curves, DCA, and calibration analysis demonstrated the superior disease prediction accuracy of this model. In addition, using proteomic analysis, we investigated whether these key hub genes interact with the HBV-encoded oncogene X protein (HBx), the oncogenic protein in HCC. We constructed stable HBx-expressing LO2-HBx and Huh-7-HBx cell lines. Co-immunoprecipitation coupled with mass spectrometry (Co-IP/MS) results demonstrated that CDK1, RRM2, ANLN, and HMMR interacted specifically with HBx in both cell models. Importantly, we investigated 15 potential key genes (CCNB1, CDK1, BUB1B, ECT2, RACGAP1, ANLN, PBK, TOP2A, ASPM, RRM2, NEK2, PRC1, SPP1, HMMR, and DTL) participating in the transformation process of HBV infection to HCC, of which 4 hub genes (CDK1, RRM2, ANLN, and HMMR) probably serve as potential oncogenic HBx downstream target molecules. All these findings of our study provided valuable research direction for the diagnostic gene detection of HBV-related HCC in primary care surveillance for HCC in patients with cirrhosis.

Role of Galectin-3 in Enhancing HBV Replication and Predicting Hepatocellular Carcinoma: Mechanistic Insights and Clinical Implications

Discovering Potential Serological Biomarker for Chronic Hepatitis B Virus-related Hepatocellular Carcinoma in Chinese Population by MAL-associated Serum Glycoproteomics Analysis

Galectin-3 Not Galectin-9 As a Candidate Prognosis Marker for Hepatocellular Carcinoma.

Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Hepatitis B Virus Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients

Glypican‐3: A Promising Biomarker for Hepatocellular Carcinoma Diagnosis and Treatment

Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Chronic Hepatitis Virus B Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients

Galectin-3 is Associated with a Poor Prognosis in Primary Hepatocellular Carcinoma

Galectin-9 Expression Predicts Poor Prognosis in Hepatitis B Virus-Associated Hepatocellular Carcinoma

Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

Role of GALAD serological model in the clinical diagnosis of primary hepatocellular carcinoma

Downregulation of Galectin-3 Causes A Decrease in Upar Levels and Inhibits the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells

Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis.

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection

Overexpression of ST3Gal-I Promotes Migration and Invasion of HCCLM3 in Vitro and Poor Prognosis in Human Hepatocellular Carcinoma

The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC

GPC-3 in Hepatocellular Carcinoma: Current Perspectives

Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation

Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma

Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma